Related Experiment Video
Updated: Jun 11, 2025

08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
10.6K
Modeling of Parkinson's Disease in Different Models
Iqra Subhan1, Yasir Hasan Siddique1
1Laboratory of Alternative Animal Models, Section of Genetics, Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, 202002, Uttar Pradesh, India.
CNS & Neurological Disorders Drug Targets
|October 2, 2024
Summary
Animal models are crucial for understanding Parkinson's Disease (PD) mechanisms, offering insights into genetic and environmental factors. This review critically examines various PD animal models, comparing their strengths and weaknesses to human disease manifestations.
Area of Science:
- Neuroscience
- Pathology
- Animal Models
Background:
- Parkinson's Disease (PD) is a progressive neurodegenerative disorder with unknown causes.
- Animal models are vital for studying PD's development and mechanisms.
- Toxic and transgenic models have unique characteristics and limitations.
Purpose of the Study:
- To critically review and examine animal models of Parkinson's Disease.
- To compare the features of animal models with human PD manifestations.
- To guide the selection of appropriate animal models for PD research.
Main Methods:
- Literature review of toxic and transgenic animal models for PD.
- Comparative analysis of model characteristics against human PD.
- Examination of cellular and molecular processes in PD models.
Main Results:
- Animal models have elucidated cellular and molecular pathways in PD.
- Models suggest a complex interplay of genetic and environmental factors in PD etiology.
- Each model type (toxic, transgenic) presents distinct advantages and disadvantages.
Conclusions:
- Animal models are indispensable tools for Parkinson's Disease research.
- Careful selection of PD animal models is essential for valid research outcomes.
- Understanding model limitations is key to translating findings to human PD.
Related Concept Videos
Parkinson's Disease: Overview
492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492
Parkinson's Disease: Treatment
233
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
233
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K

